Compare SUPN & CPRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUPN | CPRI |
|---|---|---|
| Founded | 2005 | 1981 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.9B |
| IPO Year | 2010 | 2011 |
| Metric | SUPN | CPRI |
|---|---|---|
| Price | $55.61 | $19.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 14 |
| Target Price | ★ $61.60 | $26.50 |
| AVG Volume (30 Days) | 740.4K | ★ 3.5M |
| Earning Date | 05-21-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.18 |
| Revenue | $392,755,000.00 | ★ $4,442,000,000.00 |
| Revenue This Year | $23.19 | N/A |
| Revenue Next Year | $17.65 | $1.81 |
| P/E Ratio | ★ N/A | $16.10 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $29.16 | $11.86 |
| 52 Week High | $59.68 | $28.27 |
| Indicator | SUPN | CPRI |
|---|---|---|
| Relative Strength Index (RSI) | 63.79 | 34.83 |
| Support Level | $47.95 | $16.62 |
| Resistance Level | $58.67 | $19.62 |
| Average True Range (ATR) | 2.26 | 0.95 |
| MACD | 0.38 | -0.03 |
| Stochastic Oscillator | 60.13 | 17.72 |
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. John Idol has served as Capri's CEO since 2003.